BMED vs. BBC
Compare and contrast key facts about Future Health ETF (BMED) and Virtus LifeSci Biotech Clinical Trials ETF (BBC).
BMED and BBC are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. BMED is an actively managed fund by BlackRock. It was launched on Sep 29, 2020. BBC is a passively managed fund by Virtus Investment Partners that tracks the performance of the LifeSci Biotechnology Clinical Trials Index. It was launched on Dec 16, 2014.
Performance
BMED vs. BBC - Performance Comparison
Loading graphics...
BMED vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
BMED Future Health ETF | -4.58% | 21.79% | 1.55% | 5.70% | -19.69% | -3.96% | 17.86% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 7.95% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 25.70% |
Returns By Period
In the year-to-date period, BMED achieves a -4.58% return, which is significantly lower than BBC's 7.95% return.
BMED
- 1D
- 2.68%
- 1M
- -6.75%
- YTD
- -4.58%
- 6M
- 7.95%
- 1Y
- 19.34%
- 3Y*
- 7.27%
- 5Y*
- 0.33%
- 10Y*
- —
BBC
- 1D
- 7.67%
- 1M
- -1.98%
- YTD
- 7.95%
- 6M
- 55.07%
- 1Y
- 141.32%
- 3Y*
- 25.09%
- 5Y*
- -3.63%
- 10Y*
- 8.41%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
BMED vs. BBC - Expense Ratio Comparison
BMED has a 0.85% expense ratio, which is higher than BBC's 0.79% expense ratio.
Return for Risk
BMED vs. BBC — Risk / Return Rank
BMED
BBC
BMED vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Future Health ETF (BMED) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMED | BBC | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.07 | 3.52 | -2.45 |
Sortino ratioReturn per unit of downside risk | 1.54 | 3.86 | -2.31 |
Omega ratioGain probability vs. loss probability | 1.21 | 1.47 | -0.27 |
Calmar ratioReturn relative to maximum drawdown | 1.51 | 6.54 | -5.03 |
Martin ratioReturn relative to average drawdown | 5.06 | 25.10 | -20.04 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| BMED | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.07 | 3.52 | -2.45 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.02 | -0.09 | +0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.22 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.12 | +0.01 |
Correlation
The correlation between BMED and BBC is 0.77, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
BMED vs. BBC - Dividend Comparison
BMED has not paid dividends to shareholders, while BBC's dividend yield for the trailing twelve months is around 1.57%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BMED Future Health ETF | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
Drawdowns
BMED vs. BBC - Drawdown Comparison
The maximum BMED drawdown since its inception was -36.44%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for BMED and BBC.
Loading graphics...
Drawdown Indicators
| BMED | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.44% | -76.85% | +40.41% |
Max Drawdown (1Y)Largest decline over 1 year | -12.31% | -18.03% | +5.72% |
Max Drawdown (5Y)Largest decline over 5 years | -33.90% | -72.58% | +38.68% |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.85% | — |
Current DrawdownCurrent decline from peak | -10.60% | -30.71% | +20.11% |
Average DrawdownAverage peak-to-trough decline | -19.30% | -37.30% | +18.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.67% | 5.05% | -1.38% |
Volatility
BMED vs. BBC - Volatility Comparison
The current volatility for Future Health ETF (BMED) is 6.08%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 13.21%. This indicates that BMED experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| BMED | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.08% | 13.21% | -7.13% |
Volatility (6M)Calculated over the trailing 6-month period | 11.07% | 26.93% | -15.86% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.25% | 40.92% | -22.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.43% | 39.30% | -21.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.82% | 37.86% | -20.04% |